Active Ingredient: ADENOSINE
Proprietary Name: ADENOCARD
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019937
Product Number: 002
Approval Date: Oct 30, 1989
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
